Hospitals could reduce unnecessary tests for cardiac diagnostic imaging

Sep 12, 2008

Hospitals that perform cardiac nuclear stress testing under published national practice guidelines could reduce unnecessary testing and, potentially costs, according to a Henry Ford Hospital study.

The study looked at 375 patients who underwent nuclear stress testing at Henry Ford and showed that in the majority of cases, 90 percent, physicians ordered the diagnostic imaging test appropriately using the updated 2007 Appropriateness Criteria of the American Society of Nuclear Cardiology (ACNC) and American College of Cardiology.

However, researchers also found that 21 patients should not have received the test because their patient profile and assessment didn't meet the test criteria under the guidelines. While these patients were considered low risk for nuclear testing, none required additional testing such as a cardiac catheterization and 95 percent of the scans in the group turned up normal.

Karthik Ananth, M.D., a Henry Ford cardiologist and the study's senior author, and cardiology fellow Natesh Lingam will present the findings Friday, Sept. 12 at the American Society of Nuclear Cardiology Conference in Boston.

While the Henry Ford study did not look at cost, researchers theorize there is potential for savings based on their findings. Further study will be required to determine the cost analysis, researchers say.

"We believe there is potential for substantial savings provided hospitals closely adhere to these test-appropriateness criteria for cardiac nuclear testing," says Dr. Ananth.

"When followed, these criteria help physicians ensure the most effective use of cardiac nuclear testing and provide them simple clinical tools to filter out low-risk patients in whom unnecessary testing can be avoided."

These criteria were developed by an expert panel of physicians in response to a Medicare Payment Advisory Commission report showing that cardiac imaging services rose twice the rate of growth of other physician services from 1999-2003. Based originally on existing medical evidence and the most common clinical reasons for ordering stress testing, the criteria were published in 2005 and updated two years later to guide physicians to use nuclear testing more responsibly and cost effectively.

A cardiac nuclear test is a non-invasive procedure that measures arterial blood flow to the heart during physical or chemical stress. When compared to blood flow during rest, the test reflects imbalances of blood flow to the heart's left ventricular muscle tissue – the part of the heart that performs the greatest amount of work pumping blood.

Henry Ford performs about 4,000 cardiac nuclear tests annually, among the lowest in Michigan. Roughly 8 million nuclear tests are performed nationally, nearly double from 10 years ago. Patients are exposed to a small amount of radiation during the four-hour test, which costs about $4,000. Most insurance plans pay for the test.

In the study, Henry Ford researchers evaluated the practice patterns of their own cardiologists and non-cardiologists who ordered a cardiac nuclear test for patients between January-March 2007. The goal was to determine whether physicians adhered to the 52 criteria outlining when a test is appropriate or inappropriate.

The criteria aid physicians in identifying whether a patient should receive the nuclear test based on their medical profile. Of the 52, 27 indicators are listed for appropriate testing, 13 indicators for inappropriate testing and 12 indicators for uncertain, meaning testing may be acceptable but that additional research is needed to determine these criteria are appropriate or inappropriate.

Source: Henry Ford Health System

Explore further: AMA: Gender inequality still exists in medicine

add to favorites email to friend print save as pdf

Related Stories

Embryonic stem cells: Reprogramming in early embryos

Mar 26, 2014

An Oregon Health & Science University scientist has been able to make embryonic stem cells from adult mouse body cells using the cytoplasm of two-cell embryos that were in the "interphase" stage of the cell ...

Recommended for you

New medical device to make the mines safer

Nov 21, 2014

Dehydration can be a serious health issue for Australia's mining industry, but a new product to be developed with input from Flinders University's Medical Device Partnering Program (MDPP) is set to more effectively ...

US family gets $6.75 million in Botox case

Nov 20, 2014

A New York couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications and sued its manufacturer won a $6.75 million verdict from a federal jury on Thursday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.